Drug Profile
Quinoline quinone derivatives
Latest Information Update: 14 May 1998
Price :
$50
*
At a glance
- Originator Bentley Pharmaceuticals
- Class Antibacterials
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycobacterium avium complex infections
Most Recent Events
- 14 May 1998 Discontinued-Preclinical for Mycobacterium avium complex infections in USA (Unknown route)
- 15 Feb 1996 Belmac is now known as Bentley Pharmaceuticals
- 17 May 1995 New profile